Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease

In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences

(2021) June van Aalst et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study

(2021) Ming-Kai Chen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study

(2021) Laura Michiels et al.   NEUROIMAGE

PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression

(2020) Patrik Fazio et al.   MOVEMENT DISORDERS

Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease

(2020) Aline Delva et al.   MOVEMENT DISORDERS

Axonal transport: Driving synaptic function

(2019) Pedro Guedes-Dias et al.   SCIENCE

Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue

(2018) Michel Koole et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters

(2018) Diego Alfonso López Mora et al.   CLINICAL NUCLEAR MEDICINE

[18F]FDG PET signal is driven by astroglial glutamate transport

(2017) Eduardo R Zimmer et al.   NATURE NEUROSCIENCE

Glucose utilization: still in the synapse

(2017) A Jon Stoessl   NATURE NEUROSCIENCE

Striatal Local Circuitry: A New Framework for Lateral Inhibition

(2017) Dennis A. Burke et al.   NEURON

Molecular Imaging Markers to Track Huntington’s Disease Pathology

(2017) Heather Wilson et al.   Frontiers in Neurology

Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain

(2016) U. Rüb et al.   BRAIN PATHOLOGY

Glucose consumption of inflammatory cells masks metabolic deficits in the brain

(2016) Heiko Backes et al.   NEUROIMAGE

Imaging synaptic density in the living human brain

(2016) Sjoerd J. Finnema et al.   Science Translational Medicine

Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington’s disease

(2015) Robert Christian Wolf et al.   JOURNAL OF NEUROLOGY

Huntington disease

(2015) Gillian P. Bates et al.   Nature Reviews Disease Primers

Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease

(2014) G. A. Smith et al.   HUMAN MOLECULAR GENETICS

Huntington disease: natural history, biomarkers and prospects for therapeutics

(2014) Christopher A. Ross et al.   Nature Reviews Neurology

Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice

(2013) Y.P. Deng et al.   NEUROBIOLOGY OF DISEASE

Degeneration of the Cerebellum in Huntington's Disease (HD): Possible Relevance for the Clinical Picture and Potential Gateway to Pathological Mechanisms of the Disease Process

(2012) Udo Rüb et al.   BRAIN PATHOLOGY

Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease

(2012) Paul G. Unschuld et al.   NEUROSCIENCE LETTERS

The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease

(2011) Benjamin A. Thomas et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo

(2010) K. Van Laere et al.   JOURNAL OF NUCLEAR MEDICINE

Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington’s disease

(2009) Caroline K. Jurgens et al.   JOURNAL OF NEUROLOGY